Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network

This study aimed to analyze key hub genes related to pyroptosis in gout and construct a miRNA-mRNA regulatory network using bioinformatic tools to elucidate the pathogenesis of gout and offer novel ideas to develop targeted therapeutic strategies for gout. Methods: The GSE160170 dataset was downloaded from the GEO database. The expression data extracted from the dataset were used to screen for differentially expressed genes (DEGs), which intersected with pyroptosis-related genes. These DEGs were analyzed via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and a protein–protein interaction (PPI) network was constructed to identify pyroptosis-related hub DEGs. The relationship between upstream miRNAs and the hub genes was analyzed, miRNA-mRNA networks belonging to gout disease were constructed and samples from patients with gout were used for experimental verification. The CTDbase tool was used to analyze the identified hub genes and construct a molecular docking model. Results: A total of 943 DEGs (380 upregulated and 563 downregulated) were identified by analyzing the data of patients with early-stage gout and healthy control individuals in the GSE160170 dataset. DEGs and pyroptosis-related genes were intersected to obtain 17 pyroptosis-related DEGs associated with gout; of which, 12 were upregulated, and five were downregulated. The results of GO and KEGG analyses revealed that the DEGs were enriched in inflammatory and immune signaling pathways. Additionally, the DEGs were found to regulate inflammatory responses and were associated with apoptosis. TNF, IL-1β, NLRP3, CXCL8, PTGS2, NFE2L2, CASP8, and CD274 were identified as key hub genes in the PPI network, and a miRNA-mRNA network was constructed, which had 16 edges. Experimental validation revealed that PTGS2 and NFE2L2 were significantly upregulated, and CASP8 and CD274 were significantly downregulated in gout. In addition, miR-128-3p, miR-16-5p, miR-155-5p, and miR-20a-5p (associated with the miRNA-mRNA regulatory network) were significantly downregulated in gout. Five potential therapeutic drugs with stable PTGS2 binding were selected to develop a molecular docking model. Conclusion: A miRNA-mRNA potential regulatory network was constructed based on pyroptosis-related DEGs associated with gout. miR-16-5p, miR-128-3p, miR-20a-5p, and miR-155-5p can potentially influence pyroptosis and the occurrence and development of gout by affecting the expression of the PTGS2, CASP8, NFE2L2, and CD274 genes. Screening of celecoxib and resveratrol and other targeted drugs with stable binding. The findings of this study offer valuable insights into the regulatory mechanisms of gout and may help to identify Biomarkers and develop targeted therapeutic strategies for gout.

[1]  J. Mudgal,et al.  Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors , 2021, Scandinavian journal of immunology.

[2]  T. Wróbel,et al.  Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases , 2021, International journal of molecular sciences.

[3]  Jian Xiao,et al.  Pyroptosis in diabetic nephropathy. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[4]  Junxia Cui,et al.  microRNA-148 is involved in NF-κB signaling pathway regulation after LPS stimulation by targeting IL-1β in miiuy croaker. , 2021, Fish & shellfish immunology.

[5]  R. Terkeltaub,et al.  Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. , 2021, The American journal of medicine.

[6]  Lingling Zhu,et al.  Protective effects of miR-155-5p silencing on IFN-γ-induced apoptosis and inflammation in salivary gland epithelial cells , 2021, Experimental and therapeutic medicine.

[7]  Qiang Wang,et al.  Bioinformatics Analysis Identifies Potential Ferroptosis Key Genes in the Pathogenesis of Intracerebral Hemorrhage , 2021, Frontiers in Neuroscience.

[8]  Z. Bao,et al.  Pyroptosis in the Initiation and Progression of Atherosclerosis , 2021, Frontiers in Pharmacology.

[9]  Y. Qing,et al.  MicroRNA-223 Suppresses IL-1β and TNF-α Production in Gouty Inflammation by Targeting the NLRP3 Inflammasome , 2021, Frontiers in Pharmacology.

[10]  Chufeng Gu,et al.  Integrative analysis of miRNA–mRNA network in high altitude retinopathy by bioinformatics analysis , 2021, Bioscience reports.

[11]  Jie Cao,et al.  Identification and Validation of Autophagy-Related Genes in Chronic Obstructive Pulmonary Disease , 2021, International journal of chronic obstructive pulmonary disease.

[12]  Thomas C. Wiegers,et al.  Comparative Toxicogenomics Database (CTD): update 2021 , 2020, Nucleic Acids Res..

[13]  Shuguang Chen,et al.  MiR-128-3p Post-Transcriptionally Inhibits WISP1 to Suppress Apoptosis and Inflammation in Human Articular Chondrocytes via the PI3K/AKT/NF-κB Signaling Pathway , 2020, Cell transplantation.

[14]  Lingyi Kong,et al.  MicroRNA and long noncoding RNA involvement in gout and prospects for treatment. , 2020, International immunopharmacology.

[15]  A S Ben Geoffrey,et al.  A program to automate the discovery of drugs for West Nile and Dengue virus – programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling , 2020, bioRxiv.

[16]  M. Pillinger,et al.  Therapeutic approaches in the treatment of gout. , 2020, Seminars in arthritis and rheumatism.

[17]  J. Singh,et al.  Gout epidemiology and comorbidities. , 2020, Seminars in arthritis and rheumatism.

[18]  D. Green,et al.  Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis. , 2020, Immunity.

[19]  Qianqian Wang,et al.  Gout: a disease involved with complicated immunoinflammatory responses: a narrative review , 2020, Clinical Rheumatology.

[20]  Y. Qing,et al.  LncRNAs Landscape in the patients of primary gout by Microarray Analysis , 2020, bioRxiv.

[21]  Jing Wang,et al.  LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α. , 2020, International immunopharmacology.

[22]  Karuppasamy Muthuvel Prasath,et al.  PDB-2-PBv3.0: An updated protein block database , 2020, J. Bioinform. Comput. Biol..

[23]  J. Ji,et al.  MicroRNA‐155‐5p suppresses PD‐L1 expression in lung adenocarcinoma , 2020, FEBS open bio.

[24]  Yin‐peng Jin,et al.  miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis , 2020, Frontiers in Oncology.

[25]  Fangli Lv,et al.  MicroRNA-101-3p inhibits fibroblast-like synoviocyte proliferation and inflammation in rheumatoid arthritis by targeting PTGS2 , 2020, Bioscience reports.

[26]  Trung Hai Nguyen,et al.  Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity , 2019, J. Chem. Inf. Model..

[27]  M. Pasparakis,et al.  Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis , 2019, Nature.

[28]  E. Ballestar,et al.  miRNAs as Therapeutic Targets in Inflammatory Disease. , 2019, Trends in pharmacological sciences.

[29]  H. Weiner,et al.  Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity , 2019, Cell reports.

[30]  Kun Zhang,et al.  LncRNA SNHG1 alleviates IL-1β-induced osteoarthritis by inhibiting miR-16-5p-mediated p38 MAPK and NF-κB signaling pathways , 2019, Bioscience reports.

[31]  Othman Soufan,et al.  NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..

[32]  C. Bokemeyer,et al.  Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  E. Lianidou,et al.  Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes , 2019, Translational research : the journal of laboratory and clinical medicine.

[34]  Mei Zeng,et al.  Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity. , 2019, International immunopharmacology.

[35]  W. Xie,et al.  Resveratrol ameliorates gouty inflammation via upregulation of sirtuin 1 to promote autophagy in gout patients , 2019, Inflammopharmacology.

[36]  Weifeng Liu,et al.  Structures of Immune Checkpoints: An Overview on the CD28-B7 Family. , 2019, Advances in experimental medicine and biology.

[37]  I. MacRae,et al.  Regulation of microRNA function in animals , 2018, Nature Reviews Molecular Cell Biology.

[38]  Zhangyi Wu,et al.  MicroRNA-128 inhibits proliferation and invasion of glioma cells by targeting COX-2. , 2018, Gene.

[39]  M. Skoblov,et al.  Efficiency of the miRNA–mRNA Interaction Prediction Programs , 2018, Molecular Biology.

[40]  T. Jin,et al.  Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes. , 2018, Trends in immunology.

[41]  R. Ammendola,et al.  miR-128 Is Implicated in Stress Responses by Targeting MAFG in Skeletal Muscle Cells , 2017, Oxidative medicine and cellular longevity.

[42]  E. Reddy,et al.  JNK-signaling: A multiplexing hub in programmed cell death , 2017, Genes & cancer.

[43]  Si Ming Man,et al.  Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases , 2017, Immunological reviews.

[44]  J. Ma,et al.  Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells. , 2017, European review for medical and pharmacological sciences.

[45]  Akhileshwar Namani,et al.  Nrf2 signaling pathway: Pivotal roles in inflammation. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[46]  Shirley W. I. Siu,et al.  PyMOL mControl: Manipulating molecular visualization with mobile devices , 2017, Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology.

[47]  Tsviya Olender,et al.  Genic insights from integrated human proteomics in GeneCards , 2016, Database J. Biol. Databases Curation.

[48]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[49]  A. Ogdie,et al.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.

[50]  K. S. Kim,et al.  Protective effects of Fc-fused PD-L1 on two different animal models of colitis , 2014, Gut.

[51]  Q. Ma.  Role of nrf2 in oxidative stress and toxicity. , 2013, Annual review of pharmacology and toxicology.

[52]  F. Perez-Ruiz,et al.  Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial , 2012, The Journal of Rheumatology.

[53]  Zheng Wang,et al.  Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Soo Kon Lee,et al.  Pathophysiology of Gout , 2011 .